nasosinusitis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients aged 18-60 years.with chronic sinusitis who have undergone endoscopic surgery. Voluntarily enrolled in this study, signed an informed consent form, had good compliance and were willing to cooperate with follow-up.
Exclusion criteria
Exclusion criteria: 1) Participants who have received radiotherapy, chemotherapy, surgery (excluding local biopsy) or molecular targeted therapy within 4 weeks prior to enrollment; or who have received anti-tumor endocrine therapy after screening period. 2) Participants with a history of other malignant tumors. 3) Participants with a history of immune deficiency, including positive HIV test, or other acquired or congenital immune deficiency diseases, or a history of organ transplantation. 4) Participants with any history of cardiovascular disease, including: 1) cardiac arrhythmia requiring medication or of clinical significance; 2) myocardial infarction; 3) heart failure; 4) any other cardiovascular disease deemed by the investigator to be unsuitable for participation in this trial, etc. 5) Participants with a history of a definitive neurological or psychiatric disorder, including epilepsy or dementia. 6) Female patients who are pregnant or breastfeeding, have reproductive potential and have a positive baseline pregnancy test, or are unwilling to take effective contraceptive measures during the trial period. 7) Participants with severe co-existing diseases. 8) Any other situation where the investigator deems the participant unsuitable for participation in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Nasal conditions;Sinus conditions;Olfactory function score;Surgical related complications; | — |
Secondary
| Measure | Time frame |
|---|---|
| Safety indicators; | — |
Countries
China
Contacts
Second Affiliated Hospital of Army Medical University